PUYOU de POUVOURVILLE Gérard
Department : Economics
Emeritus Professor
Campus de Cergy
Contact
- email : pouvourville@essec.edu
- tél : +33 (0)1 34 43 30 10
Personal links
Diplomas
- 1978 : Doctorate in Economics and Business Administration (Aix-Marseille Université, France )
- 1974 : Diplôme d'Etudes Supérieures in Economics (Université Paris 1 Panthéon-Sorbonne, France )
- 1970 : Graduate (Ecole Polytechnique, France )
Career
- 2019 - Present : Emeritus Professor (ESSEC Business School, France)
- 2007 - 2019 : Professor (ESSEC Business School, France)
- 2000 - 2006 : Head of the Etudes Médico-Economiques, part-time role (Institut Gustave Roussy, France)
- 2000 - 2006 : Lecturer, with Monique Kerleau, "Approche économique et théorie des organisations appliquées au système de soins", DESS Economie et Gestion des systèmes de santé (Université Paris 1 Panthéon-Sorbonne, France)
- 2000 - 2006 : Supervisor of Economics and Management courses, Master Santé Publique, M1 (University Paris-Saclay, France)
- 2000 - 2006 : Track Head, "Economie de la Santé", Master 2 Santé Publique. Teaching and Dissertation mentoring (University Paris-Saclay, France)
- 2003 - 2006 : Head of the Research Program « Epidémiologie, Santé Publique, Economie de la Santé et Sciences Humaines et Sociales », at the Direction de la Recherche (Institut Gustave Roussy, France)
- 2004 - 2006 : Lecturer, Module « Préparation à la vie professionnelle », DCEM2, Faculté de Médecine de Bicêtre (University Paris-Saclay, France)
- 2006 : Research teams manager, CERMES, INSERM U750, CNRS UMR 8169 (Institut national de la santé et de la recherche médicale (INSERM), France)
- 2000 - 2005 : Head of the Centre de Recherche en Economie et Gestion Appliquées à la Santé, INSERM U537, CNRS UMR 8052. (Institut national de la santé et de la recherche médicale (INSERM), France)
- 1998 - 2001 : Associate Professor, Université de Lausanne (HEC Lausanne, Switzerland)
- 1993 - 2000 : Scientific Director of Groupe Information Médicale et Aide à la Gestion des Etablissements (IMAGE); by the CNRS. (Ecole Nationale de la Santé Publique, France)
- 1994 - 1999 : Lecturer, Faculté de Médecine Saint-Louis-Lariboisière; teacher for the DEA "Système de soins hospitaliers et Société" (Director: Dominique Bertrand). Seminar "Evaluation des coûts à l'hôpital", seminar (with Alain Fontaine) "Préparation du mémoire de DEA". (University of Paris, France)
- 1986 - 1993 : Lecturer; DEA 103 "Méthodes Scientifiques de Gestion" (Professor Bernard Roy) (Université Paris Dauphine, France)
- 1989 - 1993 : Research Director, 2nd class, Centre de Recherche en Gestion (Ecole Polytechnique, France)
- 1989 - 1992 : Research fellow, Groupe IMAGE (Ecole Nationale de la Santé Publique, France)
- 1981 - 1989 : Research fellow, CNRS, Centre de Recherche en Gestion (Ecole Polytechnique, France)
- 1986 : Invited Researcher at Groupe de Recherche Interdisciplinaires en Santé (GRIS). Expert invited at the Commission d'Enquête sur les Services Sociaux et de Santé, Gouvernement du Québec. (Université de Montréal, Canada)
- 1984 : Guest Researcher, Leonard Davis Institute for Health Economics (University of Pennsylvania, United States of America)
- 1978 - 1981 : Researcher, Centre de Recherche en Gestion (Ecole Polytechnique, France)
- 1979 - 1980 : Part-time lecturer, Institut Auguste Comte pour l'Etude des Sciences de l'Action. (Ecole Polytechnique, France)
- 1973 - 1978 : Doctorate, Centre de Recherche en Gestion (Ecole Polytechnique, France)
- 1973 - 1977 : Economics class lecturer. In charge of the organization of final internships in Economics and Management. (Ecole Polytechnique, France)
- 1976 - 1977 : Economics classes lecturer (Ecole Nationale du Génie Rural et des Eaux et Forêts (ENGREF), France)
Full-time academic appointments
Other Academic Appointments
Journal articles
- DE POUVOURVILLE, G., BLIN, P. and KARAM, P. (2020). The Contribution of Real-World Evidence to Cost-Effectiveness Analysis: Case Study of Dabigatran Etexilate in France. European Journal of Health Economics, 21, pp. 235-249.
- ANDRADE, L.F., LUDWIG, K., RAMOS GONI, J.M., OPPE, M. and DE POUVOURVILLE, G. (2020). A French Value Set for the EQ‐5D‐5L. Pharmacoeconomics, 38, pp. 413–425.
- PUYOU DE POUVOURVILLE, G., TÉHARD, B., DETOURNAY, B., BORGET, I. and ROZE, S. (2020). The Value of a QLY for France: a newapproach topropose acceptable reference values. Value in Health, 23(8), pp. 985-993.
- CHOUAID, C., GERMAIN, N., PUYOU DE POUVOURVILLE, G., ABALLEA, S., KORCHAGINA, D. and BALDWIN, M. (2019). Patient preference for chronic obstructive pulmonary disease (COPD) treatment inhalers: a discrete choice experiment in France. Current Medical Research and Opinion,, pp. 785-792.
- DE POUVOURVILLE, G. and KARAM, P. (2019). Le coût hospitalier des événements cérébro-vasculaires associés à une fibrillation atriale en France. Journal de Gestion et d'Économie de la Santé, 37(5), pp. 399-409.
- GOODALL, G., LAMOTTE, M., RAMOS, S., MAUNOURY, F., PEJCHALOVA, B. and DE POUVOURVILLE, G. (2018). Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients. Journal of Medical Economics, 22(4), pp. 289-296.
- PUYOU DE POUVOURVILLE, G. (2016). Anticoagulants d'action directe: une revue de la littérature des études coût/efficacité en Europe. Archives of Cardiovascular Diseases Supplements, 8(2), pp. 180-191.
- PERSONNE, V., CHEVALIER, J., BUFFEL DU VAURE, C., PARTOUCHE, H., GILBERG, S. and DE POUVOURVILLE, G. (2016). CAPECO: Cost Evaluation of Community Acquired Pneumonia Managed in Primary Care. Vaccine, 19(34), pp. 2275-2280.
- PUYOU DE POUVOURVILLE, G. (2016). Comment Améliorer le Suivi des AVK et pour quel Coût?. Archives of Cardiovascular Diseases Supplements, 2(8), pp. 169-173.
- PUYOU DE POUVOURVILLE, G. (2016). Coût de la Prise en Charge des Accidents Vasculaires Cérébraux en France. Archives of Cardiovascular Diseases Supplements, 8(2), pp. 161-168.
- PUYOU DE POUVOURVILLE, G. (2016). La Tarification à l’Activité est-elle Compatible avec les Valeurs des Professionnels de Santé ?. Médecine de l’Homme,(15), pp. 11-25.
- PUYOU DE POUVOURVILLE, G. (2016). Quel prix payer pour un bénéfice en santé ?. SEP et Neurosciences,(5), pp. 4-11.
- COHEN, A. and PUYOU DE POUVOURVILLE, G. (2016). Rapport coût/efficacité des traitements médicamenteux et interventionnels dans la fibrillation atriale. Archives of Cardiovascular Diseases Supplements, 8(2), pp. 141-143.
- BELHASSEN, M., DE BLIC, J., LAFOREST, L., LAIGLE, V., CHANUT-VOGEL, C. and DE POUVOURVILLE, G. (2016). Recurrent Wheezing in Infants. Medicine, 95(15).
- DRUMMOND, M., PUYOU DE POUVOURVILLE, G., JONES, E., HAIG, J., SABA, G. and CAWSTON, H. (2014). A Comparative Analysis of Two Contrasting European Approaches for Rewarding the Value Added by Drugs for Cancer: England Versus France. Pharmacoeconomics, 32(5), pp. 509-520.
- BONASTREA, J., CHEVALIER, J., VAN DER LAANC, C., DELIBESC, M. and PUYOU DE POUVOURVILLE, G. (2014). Access to Innovation: Is there a Difference in the Use of Expensive Anticancer Drugs Between French Hospitals?. Health Policy,(2&3), pp. 162-169.
- PUYOU DE POUVOURVILLE, G. (2013). Editorial: HAS to be NICE?. European Journal of Health Economics, 14, pp. 363-366.
- PUYOU DE POUVOURVILLE, G. (2013). Editorial: Paying Doctors for Performance. European Journal of Health Economics, 14(1), pp. 1-4.
- CHEVALIER, J., GIROUD, M. and PUYOU DE POUVOURVILLE, G. (2013). Modeling of the Impact on Health Outcomes of the Use of Dabigatran in Patients with Atrial Fibrillation. Cerebrovascular Diseases, 35(4), pp. 320-326.
- RENARD, J.P., ROULAND, J.F., BRON, A., SELLEM, E., NORDMANN, J.P. and DE POUVOURVILLE, G. (2013). Nutritional, Lifestyle and Environmental Factors in Ocular Hypertension and Primary Open-Angle Glaucoma: An Exploratory Case-Control Study. Acta Ophthalmologica, 61(6), pp. 505-513.
- GARRISON, L.P., TOWSE, A., BRIGGS, A., PUYOU DE POUVOURVILLE, G., GRUEGER, J. and MOHR, P.E. (2013). Performance-Based Risk-Sharing Arrangements—Good Practices for Design, Implementation, and Evaluation: Report of the ISPOR Good Practices for Performance-Based Risk-Sharing Arrangements Task Force. Value in Health, 16(5), pp. 703-719.
- LUPORSI, E., MAHI, L., MORRE, C., WERNLI, J., PUYOU DE POUVOURVILLE, G. and BUGAT, R. (2012). Evaluation of Cost Savings with Ferric Carboxymaltose in Anemia Treatment Through Its Impact on Erythropoiesis-Stimulating Agents and Blood Transfusion: French Healthcare Payer Perspective. Journal of Medical Economics, 15(2), pp. 225-232.
- SMOLDEREN, K.G., WANG, K., PUYOU DE POUVOURVILLE, G., BRÜGGENJÜRGEN, B., RÖTHER, J. and ZEYMER, U. (2012). Two-Year Vascular Hospitalisation Rates and Associated Costs in Patients at Risk of Atherothrombosis in France and Germany: Highest Burden for Peripheral Arterial Disease. European Journal of Vascular and Endovascular Surgery, 43(2), pp. 198-207.
- COTTE, F.E. and PUYOU DE POUVOURVILLE, G. (2011). Cost of Non-Persistence with Oral Biphosphonates in Post-Menopausal Osteoporosis Treatment in France. BMC Health Services Research, 151(11), pp. 1-10.
- PUYOU DE POUVOURVILLE, G. (2011). L'assurance maladie en France: Beveridge et Bismarck enfin reconciliés?. Réalités Industrielles (série des "Annales des Mines"),, pp. 19-24.
- COHEN, S.Y., SOUIED, E.H., WEBER, A.P., DUPEYRON, G., PUYOU DE POUVOURVILLE, G. and LIEVRE, M. (2011). Patient Characteristics and Treatment of Neovascular Age-related Macular Degeneration in France: The LUEUR 1 Observational Study. Graefe's Archive for Clinical and Experimental Ophthalmology, 249(4), pp. 521-527.
- BONASTRE, J., LE VAILLANT, M. and PUYOU DE POUVOURVILLE, G. (2011). The Impact of Research on Hospital Costs of Care: An Empirical Study. Health Economics, 20(1), pp. 73-84.
- CHEVALIER, J. and PUYOU DE POUVOURVILLE, G. (2011). Valuing EQ-5D using Time Trade-Off in France. European Journal of Health Economics, 14(1), pp. 57-66.
- PUYOU DE POUVOURVILLE, G. (2010). Editorial: A French Approach to Cost-Effectiveness Analysis?. European Journal of Health Economics, 11(6), pp. 521-523.
- CARO, J.J., NORD, E., MCGUIRE, A., MCGREGOR, D.H., PUYOU DE POUVOURVILLE, G. and ATELLA, V. (2010). IQWiG Methods – A Response to Two Critiques. Health Economics, 19, pp. 1137-1138.
- PUYOU DE POUVOURVILLE, G. (2010). La crise d'identité des médecins face au nouveau management de l'hôpital. Journal de l'Ecole de Paris du Management, 6(86), pp. 22-29.
- CARO, J.J., NORD, E., SIEBERT, U., MCGUIRE, A., MCGREGOR, M. and DE POUVOURVILLE, G. (2010). The Efficiency Frontier Approach to Economic Evaluation of Health-Care Interventions. Health Economics, 19(10), pp. 1117-1127.
- COTTE, F.E., FAUTREL, B. and PUYOU DE POUVOURVILLE, G. (2009). A Markov Model Simulation of the Impact of Treatment Persistence in Postmenopausal Osteoporosis. Medical Decision Making, 29(1), pp. 125-139.
- CLERC, P., LE BRETON, J., MOUSQUES, J., HEBBRECHT, G. and PUYOU DE POUVOURVILLE, G. (2009). Etude polychrome : une méthode d'expertise pour optimiser des vignettes de polyprescription en médecine générale. Pratiques et Organisation des Soins, 40(3), pp. 165-174.
- PUYOU DE POUVOURVILLE, G. (2009). Exploitation seconde de la base de l'Etude nationale de coûts (ENC). Dossiers Solidarité et santé,(9), pp. 2-6.
- NIXON, J., RICE, S., DRUMMOND, M., BOULENGER, S., ULMANN, P. and DE POUVOURVILLE, G. (2009). Guidelines for Completing the EURONHEED Transferability Information Checklists. European Journal of Health Economics, 10(2), pp. 157-165.
- PUYOU DE POUVOURVILLE, G. (2009). Les hôpitaux français face au paiement prospectif au cas. La mise en œuvre de la tarification à l'activité. Revue Economique, 60(2), pp. 457-470.
- TIBI-LEVY, Y. and PUYOU DE POUVOURVILLE, G. (2009). Qu'est-ce qu'une unité de soins "performante", du point de vue des malades relevant de soins palliatifs et de leurs proches ?. Médecine palliative, 8(2), pp. 53-65.
- DEJARDIN, O., BOUVIER, A.M., FAIVRE, J., BOUTREUX, S., PUYOU DE POUVOURVILLE, G. and LAUNOY, G. (2008). Access to Care, Socioeconomic Deprivation and Colon Cancer Survival. Alimentary Pharmacology & Therapeutics, 27(10), pp. 940-949.
- BORGET, I., VIELH, P., LEBOULLEUX, S., ALLYN, M., IACOBELLI, S. and DE POUVOURVILLE, G. (2008). Assessment of the Cost of Fine-needle Aspiration Cytology as a Diagnostic Tool in Patients with Thyroid Nodules. American Journal of Clinical Pathology, 129(5), pp. 763-771.
- PUYOU DE POUVOURVILLE, G., SOLESSE, A. and BEILLAT, M. (2008). Cost-effectiveness Analysis of Aldosterone Blockade with Eplerenone in Patients with Heart Failure after Acute Myocardial Infarction in the French Context: The EPHESUS Study. Archives of Cardiovascular Diseases, 101(9), pp. 515-521.
- BONASTRE, J., CHEVALIER, J., ELIAS, D., CLASSE, J.M., FERRON, G. and DE POUVOURVILLE, G. (2008). Cost-effectiveness of Intraperitoneal Chemohyperthermia in the Treatment of Peritoneal Carcinomatosis from Colorectal Cancer. Value in Health, 11(3), pp. 347-353.
- CLERC, P., LEBRETON, J., MOUSQUES, J., HEBBRECHT, G. and PUYOU DE POUVOURVILLE, G. (2008). Etude polychrome : construction d'une typologie des pathologies chroniques en médecine générale, pour une analyse de la poly-prescription. Pratiques et Organisation des Soins, 39(1), pp. 43-51.
- BORGET, I., REMY, H., CHEVALIER, J., RICARD, M., ALLYN, M. and DE POUVOURVILLE, G. (2008). Length and Cost of Hospital Stay of Radioiodine Ablation in Thyroid Cancer Patients: Comparison between Preparation with Thyroid Hormone Withdrawal and Thyrogen. European Journal of Nuclear Medicine and Molecular Imaging, 35(8), pp. 1457-1463.
- COTTE, F.E., MERCIER, F. and PUYOU DE POUVOURVILLE, G. (2008). Relationship Between Compliance and Persistence with Osteoporosis Medications and Fracture Risk in Primary Health Care in France: A Retroprospective Case-control Analysis. Clinical Therapeutics, 30(12), pp. 2410-2422.
- TIBI-LEVY, Y., PUYOU DE POUVOURVILLE, G., WESTERLOPPE, J. and BAMBERGER, M. (2008). The Cost of Treating High Blood Pressure in General Practice in France. European Journal of Health Economics, 9(3), pp. 229-236.
- PUYOU DE POUVOURVILLE, G. (2007). Editorial : La réforme de la gouvernance hospitalière : mission impossible?. La Presse Médicale, 36(4), pp. 636-637.
- PUYOU DE POUVOURVILLE, G., BORGET, I. and SCHLUMBERGER, M. (2007). Health-related Quality of Life - An Economist's Perspective (Viewpoint). Nature Reviews Endocrinology, 3(12), pp. 2-3.
- SCHLUMBERGER, M., RICARD, M., PUYOU DE POUVOURVILLE, G. and PACINI, F. (2007). How the Availability of Recombinant Human TSH Has Changed the Management of Patients Who Have Thyroid Cancer. Nature Reviews Endocrinology, 3(9), pp. 641-650.
- PUYOU DE POUVOURVILLE, G. (2007). Qu'est-ce que la recherche en médecine générale ?. La Revue du Practicien, 57(11), pp. 1181-1185.
- DE POUVOURVILLE, G., BORGET, I. and SCHLUMBERGER, M. (2007). Calcitonin determination in patients with nodular thyroid disease.. The Journal of Clinical Endocrinology & Metabolism, 92(2), pp. 425-427.
- DE POUVOURVILLE, G., BONASTRE, J., DE BAÈRE, T., ELIAS, D. and SERGE, E. (2007). Cost of radiofrequency ablation in the treatment of hepatic malignancies. Gastroentérologie Clinique et Biologique, 31, pp. 828-835.
- DE POUVOURVILLE, G. and SPIELER, J.F. (2007). Evaluation du coût de la prise en charge ambulatoire des patients après AVC: résultats d'une enquête postale auprès des patients du registre des AVC de Dijon.. La Presse Médicale, 36(3), pp. 399-403.
- DE POUVOURVILLE, G., HALLAIS, C., CZERNICHOW, P., LE VAILLANT, M. and FROMENT, L. (2007). Gravité des patients et surcoüts dans les hôpitaux de référence. Journal d'Economie Médicale, 25(3), pp. 177-187.
- DE POUVOURVILLE, G., BORGET, I. and SCHLUMBERGER, M. (2007). Health-related quality of life- an economist's perspective. Nature Clinical Practice Endocrinology & Metabolism, 3, pp. 786-787.
- DE POUVOURVILLE, G. and PRIOLLET, P. (2007). Impact du choix d'une thérapie anti-agrégante dans l'artériopathie des membres inférieurs: étude coût-efficacité et impact économique. Journal des Maladies Vasculaires, 32(1), pp. 8-14.
- BONASTRE, J., CHEVALIER, J., GÉRARD, J.P., LEFKOPOULOS, D. and DE POUVOURVILLE, G. (2007). Implications of learning effects for hospital costs of new technologies: the case of intensity modulated radiation therapy. International Journal of Technology Assessment in Health Care, 23(2), pp. 248-254.
- DE POUVOURVILLE, G. (2007). La recherche en médecine générale en France: état es lieux. La Revue du Practicien, 57(11), pp. 1200-1202.
- DE POUVOURVILLE, G. (2007). Réformer la gouvernance de l'hôpital: mission impossible?. La Presse Médicale, 36(4), pp. 636-637.
- DE POUVOURVILLE, G., BORGET, I., CORONE, C., NOCAUDIE, M. and ALLYN, M. (2007). Sick leave for follow-up control in thyroid cancer patients: comparison between stimulation with Thyrogen and thyroid hormone withdrawal. European Journal of Endocrinology, 156(5), pp. 531-538.
- DE POUVOURVILLE, G., TIBI-LÉVY, Y., BAMBERGER, M. and WESTTERLOPPE, J. (2007). The cost of treating high blood pressure in France. European Journal of Health Economics,.
Book editor
Book chapters
- PUYOU DE POUVOURVILLE, G., CONTI, C. and BIBAULT, E. (2009). La distribution du médicament en France In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 427-434.
- PUYOU DE POUVOURVILLE, G. (2009). Le financement des hôpitaux In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 269-274.
- PUYOU DE POUVOURVILLE, G. (2009). L'économie de la santé : périmètre et questions de recherche In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 15-24.
- PUYOU DE POUVOURVILLE, G., BRAS, P.L. and TABUTEAU, D. (2009). L'industrie pharmaceutique en France In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 415-426.
- PUYOU DE POUVOURVILLE, G. (2009). L'organisation des soins In: Traité d'économie et de gestion de la santé. 1st ed. Presses de Sciences Po, pp. 401-406.
- D'AUNNO, T., KIMBERLY, J. and PUYOU DE POUVOURVILLE, G. (2008). Conclusions: The Global Diffusion of Casemix In: The Globalization of Managerial Innovation in Health Care. 1st ed. Cambridge University Press, pp. 346-372.
- PUYOU DE POUVOURVILLE, G. (2007). Les conséquences économiques des droits des malades In: Les droits des malades et des usagers du système de santé, une législature plus tard. 1st ed. Presses de Sciences Po, pp. 53-58.
Conference proceedings editor
Conference Proceedings
Interviews: radio, TV, press
Teaching
- 2014 - 2018 : Msc in Management of Health Industries ( ESSEC Business School Singapore)
- 2013 - 2017 : Hospital Management program (Management Général ESSEC Business School France)
- 2012 - 2015 : Heattl Technology assessmentin Asia Pacific ( ESSEC Business School Singapore)
- 2007 - 2019 : Health care Systems- Health product mrketing (Grande Ecole - Master in Management ESSEC Business School France)
Professional activities
- 1950 - Present : Invited Expert, Ministère de la Santé et du Bien-être, Province d’Alberta, Canada., Canada
- 1950 - Present : Member of the Global Health Outcome Board, Groupe Glaxo-Smith-Kline
- 1992 - Present : Member of the Groupe de Prospective Santé 2010, Commissariat Général au Plan ; writer of the health system regulation regionalization scenario (Rapport Santé 2010, under the supervision of Raymond Soubie) ; to this end writer of a synthesis presenting a creation project of Health Regional Agencies.
- 1950 - Present : Member of theCommission des Comptes de la Santé
- 1950 - Present : Scientific expert for the Mission Tarification à l’Activité, Ministère de la Santé- Participation in the working group on the topic : Financement des Missions d’Intérêt Général et d’Aide à la Contractualisation, France
- 2004 Member of the Comité d’Experts, Tarification à l’Activité, Ministère de la Santé
- 1950 - Present : Consultant for the laboratories: MSD, Sanofi-Aventis, Astra-Zeneca, Pfizer, Servier, Procter& Gamble, BMS, Bayer SA.
- 1950 - Present : Consultant, Centre Hospitalier Régional Universitaire de Lille, evaluation of the Missions d’Intérêt Général et d’Aide à la Contractualisation, as part of the Tarification à l’Activité., France
- 1950 - Present : For the Ministre de la Santé and the Ministre Délégué à la Recherche, about the development of general medicine research in France., France
- 2004 Consultant for Centre Hospitalier de Lagny-Marne-la-Vallée: implementation of intern contractualization
- 2003 Expert for the Royal Commission for the reform of the Canadian Health System (Romanow Commission)
- 2001 - 2003 : Vice-President of the Comité d'Orientation, Observatoire des Prescriptions et de la Consommation des Médicaments, Ministère de la Solidarité Nationale, de l'Emploi et de la Santé.
- 1982 - 1996 : Consultant for the Direction des Hôpitaux, Ministère de la Santé; conception of medical information systems for hospitals, in charge of the development of a budgetization method based on the medical activity of the establishments ; participation in the writing of Etude Nationale des Coûts.
- 1983 - 1984 : Consultant for Direction Générale de la Santé, Ministère de la Santé; expert for the Commission Nationale d'Anesthésiologie about specialty demography regulation.
- 1974 Consultant for OECD, on the project "Politiques pour l'innovation dans le secteur des services".
Member of an professional association, of an expert group or of a board of directors
Consulting
Research activities
- 2016 - 2018 : Gérer et Comprendre
- Reviewer for European Journal of Health Economics; Gérer et Comprendre; Health Economics; International Journal of Technology Assessment in Health Care; Pharmacoeconomics; Politiques et Management Public; Revue Française de Gestion; Social Science and Medicine
- 1989 - 1998 : Organization and co-organization of 8 symposia and research seminars, 3 of them as a member of the scientific committee of "mini-symposia" INSERM
- 2000 - 2006 : Coordinator of the Comité d'Interface INSERM/Médecine Générale
- 2001 - 2006 : Member of the Comité Directeur of IFR "Epidémiologie, Santé Publique, Sciences Sociales"
- 2000 - 2006 : Member of the Comité Scientifique Sciences Humaines et Sociales, Institut National du Cancer.
- 2002 - 2005 : Designated member of the board of directors of INSERM
- 2000 - 2005 : President of the Collège des Economistes de la Santé, member of the Conseil d’Administration , hence scientific supervisor of the organization of two international symposia ; promoter of the basis of the documentary « Connaissance et Décision en Economie de la Santé », creator of the European network (16 countries) of documentary databases in Health Economics "EURONHEED" ; co-supervisor of the writing of « Recommandations pour l’évaluation économique des stratégies de santé »., France
- 1995 - 2000 : Elected member of the Comité National, section 37 « Economie et Société »
- 1998 - 2000 : Member of the Scientific Council of Institut Paoli Calmettes
- 1997 - 2000 : Member of the Scientific Council of Institut Universitaire de Santé Publique of Ile de France
- 1995 - 1999 : Member of the Scientific Council of Ecole Nationale de la Santé Publique
- 1995 - 1998 : Member of the Scientific Council of Institut d'Etude des Politiques de Santé, Paris V.
- 1998 Member of the scientific evaluation mission of Agence Nationale de Recherche sur le SIDA, Ministère de la Recherche et de la Technologie.
- 1996 - 1998 : Scientific supervisor of the France-Québec scientific cooperation program" Economie de la Santé ".
- 1990 - 1995 : Designated member of the Scientific Council of INSERM
- 1992 - 1994 : Scientific Committee President of the invitation to tender "Evaluation Economique des Stratégies Préventives et Thérapeutiques", Ministère de la Recherche
- 1950 - Present : Member of the Scientific Council of Mission Innovation, Recherche et Expérimentation (MIRE), DREES, Ministère de la Santé, France
- 1995 - Present : Member of the Scientific Council of l’Institut de Recherche et de Documentation en Economie de la Santé (IRDES), Caisse Nationale d'Assurance Maladie, France
- 1950 - Present : Member of the Steering Committee on research operations of Haute Autorité de Santé, France
- 1950 - Present : Member of the International Health Economics Association (IHEA)
Editorial Board Membership
Reviewer for a journal
Organization of a conference or a seminar
Function in an academic association
Role as an expert or appraisor in a research organization
Member of an academic association
Theses
- 2020 : (University Paris-Saclay), Thesis director
- 2019 : (Université Paris-Descartes), Thesis referee
- 2018 : (University Paris-Saclay), Thesis referee
- 2017 : (University Paris-Saclay), Thesis director
- 2016 : (University Paris-Saclay), Thesis jury member
- 2016 : (Université Paris Dauphine), Thesis referee
- 2016 : (Université Paris Dauphine), Thesis jury member
- 2016 : (Université de Bourgogne), Thesis referee
- 2016 : (Université Paris Est Créteil), Thesis jury member
- 2016 : (Université Lyon 2), Thesis jury member
- 2015 : (Université Pierre et Marie Curie (UPMC)), Thesis referee
- 2015 : (Université Paris 1 Panthéon-Sorbonne), Thesis referee
- 2014 : (Université Paris Dauphine), Thesis referee
- 2013 : (Université Paris Dauphine), Thesis referee
- 2012 : (University Paris-Saclay), Thesis jury member
- 2012 : (Université Paris 1 Panthéon-Sorbonne), Thesis jury president
- 2011 : (Université Paris Dauphine), Thesis referee
- 2010 : (Université Paris Dauphine), Thesis referee
- 2010 : (Aix-Marseille Université), Thesis referee
- 2010 : (Université Paris Dauphine), Thesis director
- 2009 : (University Paris-Saclay), Thesis director
- 2009 : (University Paris-Saclay), Thesis director
- 2008 : (Aix-Marseille Université), Thesis referee
- 2008 : (Université Pierre et Marie Curie (UPMC)), Thesis referee
- 2008 : (University Paris-Saclay), Thesis director
- 2007 : (Université Paris Dauphine), Thesis director
- 2007 : (University Paris-Saclay), Thesis director
- 2007 : (University Paris-Saclay), Thesis director
- 2007 : (University Paris-Saclay), Thesis director
- 2007 : (University Paris-Saclay), Thesis co-director
- 2004 : (University of Caen), Thesis jury member
- 2003 : (Université Paris Diderot Paris 7 (Paris VII)), Thesis director
- 2003 : (Université Paris 1 Panthéon-Sorbonne), Thesis director
- 2003 : (Université Paris Diderot Paris 7 (Paris VII)), Thesis director
- 2003 : (Ecole Polytechnique), Thesis director
- 2002 : (Université Paris Diderot Paris 7 (Paris VII)), Thesis director
- 2001 : (Université Paris Diderot Paris 7 (Paris VII)), Thesis director
- 1999 : (Ecole Polytechnique), Thesis director, First placement: Conseil en entreprise
- 1999 : (University Paris-Saclay), Thesis director
- 1999 : (Université Paris Diderot Paris 7 (Paris VII)), Thesis director
- 1998 : (Ecole Polytechnique), Thesis director
- 1998 : (Institut d'Etudes Politiques), Thesis jury member
- 1997 : (Université Toulouse 3 Paul Sabatier), Thesis jury member
- 1997 : (Université de Bourgogne), Thesis jury member
- 1996 : (Ecole Polytechnique), Thesis director
- 1995 : (IUT Sceaux - Université Paris Sud), Thesis co-director
- 1994 : (Aix-Marseille Université), Thesis director
- 1994 : (Ecole Polytechnique), Thesis director, First placement: Université de Grenoble
- 1992 : (Ecole Polytechnique), Thesis director, First placement: INRA
- 1992 : (Ecole Polytechnique), Thesis director
- 1988 : (Ecole Polytechnique), Thesis director
- (École des hautes études en sciences sociales), Thesis referee
